Literature DB >> 10686027

Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia.

B Murgue1, C Roche, E Chungue, X Deparis.   

Abstract

The magnitude and duration of viraemia in children admitted to the hospital with dengue was studied during a dengue 2 outbreak in French Polynesia in 1996-1997. Forty-nine patients from whom at least 3 plasma samples were available were included in the study. Based on analysis of IgG-ELISA and haemagglutination inhibition assay, 21 of these were primary and 28 were secondary infections. According to World Health Organization criteria, 42 were dengue fever and 7 were dengue haemorrhagic fever. Virus was detectable by reverse transcription-PCR in all patients for at least the first 3 days of the onset of fever, but was never detected after the 6th day (mean duration = 4.4 days). Plasma virus titers ranged from 1.7-5.6 Log(10) TCID(50)/ml. A significant difference was not observed in the magnitude and duration of viraemia in patients with primary versus secondary infections. The severity of the illness, however, was correlated with both criteria. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10686027     DOI: 10.1002/(sici)1096-9071(200004)60:4<432::aid-jmv11>3.0.co;2-7

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  54 in total

1.  Dengue type 3 virus in plasma is a population of closely related genomes: quasispecies.

Authors:  Wei-Kung Wang; Su-Ru Lin; Chao-Min Lee; Chwan-Chuen King; Shan-Chwen Chang
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Detection of dengue virus replication in peripheral blood mononuclear cells from dengue virus type 2-infected patients by a reverse transcription-real-time PCR assay.

Authors:  Wei-Kung Wang; Tzu-Ling Sung; Yu-Chen Tsai; Chuan-Liang Kao; Shu-Mei Chang; Chwan-Chuen King
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

Review 3.  Dengue: defining protective versus pathologic immunity.

Authors:  Alan L Rothman
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

4.  Homology of complete genome sequences for dengue virus type-1, from dengue-fever- and dengue-haemorrhagic-fever-associated epidemics in Hawaii and French Polynesia.

Authors:  A Imrie; C Roche; Z Zhao; S Bennett; M Laille; P Effler; V-M Cao-Lormeau
Journal:  Ann Trop Med Parasitol       Date:  2010-04

Review 5.  The tortoise or the hare? Impacts of within-host dynamics on transmission success of arthropod-borne viruses.

Authors:  Benjamin M Althouse; Kathryn A Hanley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-08-19       Impact factor: 6.237

6.  Dynamic effects of antibody-dependent enhancement on the fitness of viruses.

Authors:  Derek A T Cummings; Ira B Schwartz; Lora Billings; Leah B Shaw; Donald S Burke
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-10       Impact factor: 11.205

7.  Discrimination between primary and secondary dengue virus infection by an immunoglobulin G avidity test using a single acute-phase serum sample.

Authors:  Séverine Matheus; Xavier Deparis; Bhety Labeau; Josiane Lelarge; Jacques Morvan; Philippe Dussart
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 8.  Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis.

Authors:  Karen Clyde; Jennifer L Kyle; Eva Harris
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

9.  Dengue virus evolution and virulence models.

Authors:  Rebeca Rico-Hesse
Journal:  Clin Infect Dis       Date:  2007-04-18       Impact factor: 9.079

10.  Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever.

Authors:  Anna P Durbin; Maria José Vargas; Kimberli Wanionek; Samantha N Hammond; Aubree Gordon; Crisanta Rocha; Angel Balmaseda; Eva Harris
Journal:  Virology       Date:  2008-05-02       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.